Please ensure Javascript is enabled for purposes of website accessibility
Inicio > Productos > Kits de Ensayo > Kits de Ensayo ADA
Tanezumab ELISA Kit
Tanezumab ELISA Kit
Precio(USD):
Especificación:
  • 96T
Número:
Contáctenos
  • Vista general

  • Imágenes

  • Referencias

  • Datasheet

  • SDS

Vista general
Número de catálogoDF909018
Descripción
Tanezumab ELISA Kit (DF909018) — Quantitative competitive ELISA for Tanezumab. Sample: Plasma, Serum. Range: 0.31-5 μg/mL. Sensitivity: 0.156 μg/ml.
Highlights
  • ●Competitive Format — High specificity, reliable quantification.
  • ●High Sensitivity — Optimized for low-abundance target detection.
  • ●Ready-to-Use — Complete kit with pre-coated plates included.
Tipo de muestraPlasma, Serum
Sensibilidad6.82 ng/ml
Rango156.25-10,000 ng/ml
Número de acceso P01138
Aplicaciones ELISA
Método de detección Colorimetric
Tipo de ensayo Quantitative
Recuperación 80-120%
Envío 2-8 ℃
Estabilidad y almacenamiento The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Especificaciones

Tanezumab

Nombres alternativosPF-04383119, RN624, 880266-57-9
Fondo

Beta-nerve growth factor (Tanezumab) is a ~26 kDa protein. Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. Extracellular ligand for the NTRK1 and NGFR receptors, activates cellular signaling cascades to regulate neuronal proliferation, differentiation and survival (Probable). The immature NGF precursor (proNGF) functions as a ligand for the heterodimeric receptor formed by SORCS2 and NGFR, and activates cellular signaling cascades that lead to inactivation of RAC1 and/or RAC2, reorganization of the actin cytoskeleton and neuronal growth cone collapse. In contrast to mature NGF, the precursor form (proNGF) promotes neuronal apoptosis (in vitro). Inhibits metalloproteinase-dependent proteolysis of platelet glycoprotein VI.

1. Einarsdottir, E. et al. (2004) Human molecular genetics 13, 799-805. PMID: 14976160
2. Carvalho, OP. et al. (2011) Journal of medical genetics 48, 131-5. PMID: 20978020
3. Wijeyewickrema, LC. et al. (2010) The Journal of biological chemistry 285, 11793-9. PMID: 20164177
Nota For Research Use Only.
Imágenes
  • Tanezumab ELISA Kit

    Standard Curve

    Standard Curve of Tanezumab ELISA Kit

Referencias
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recomendación

Contáctenos para cotizaciones personalizadas, solicitudes en masa y cualquier otro problema.

Correo: [email protected]

Lista de distribuidores